BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Chronic Obstructive Pulmonary Disease (COPD) |
📓
Aspergillus infection in chronic obstructive pulmonary diseases. The clinical respiratory journal (Clin Respir J ) Vol: 17 Issue 3 Pages: 129-138 Pub: 2023 Mar Epub: 2023 Jan 29 Authors Guo L , Wu X , Wu X , Html Article Publication |
| Chronic Obstructive Pulmonary Disease (COPD) |
📓
Responsiveness to pulmonary rehabilitation in COPD is associated with changes in microbiota. Respiratory research (Respir Res ) Vol: 24 Issue 1 Pages: 29 Pub: 2023 Jan 25 Epub: 2023 Jan 25 Authors Melo-Dias S , Cabral M , Furtado A , Souto-Miranda S , Mendes MA , Cravo J , Almeida CR , Marques A , Sousa A , Html Article Publication |
| Chronic Obstructive Pulmonary Disease (COPD) |
📓
Clinical Aspergillus Signatures in COPD and Bronchiectasis. Journal of fungi (Basel, Switzerland) (J Fungi (Basel) ) Vol: 8 Issue 5 Pages: Pub: 2022 May 5 Epub: 2022 May 5 Authors Tiew PY , Thng KX , Chotirmall SH , Html Article Publication |
| Chronic Obstructive Pulmonary Disease (COPD) |
📓
Corrigendum: Whole-genome analyses reveal gene content differences between nontypeable Haemophilus influenzae isolates from chronic obstructive pulmonary disease compared to other clinical phenotypes. Microbial genomics (Microb Genom ) Vol: 7 Issue 10 Pages: Pub: 2021 Oct Epub: Authors K C R , Leong KWC , Harkness NM , Lachowicz J , Gautam SS , Cooley LA , McEwan B , Petrovski S , Karupiah G , O'Toole RF , Html Article Publication |
| Chronic Obstructive Pulmonary Disease (COPD) |
📓
Inflammatory Endotype-associated Airway Microbiome in Chronic Obstructive Pulmonary Disease Clinical Stability and Exacerbations: A Multicohort Longitudinal Analysis. American journal of respiratory and critical care medicine (Am J Respir Crit Care Med ) Vol: 203 Issue 12 Pages: 1488-1502 Pub: 2021 Jun 15 Epub: Authors Wang Z , Locantore N , Haldar K , Ramsheh MY , Beech AS , Ma W , Brown JR , Tal-Singer R , Barer MR , Bafadhel M , Donaldson GC , Wedzicha JA , Singh D , Wilkinson TMA , Miller BE , Brightling CE , Html Article Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
